U.S. Markets closed

Resonance Health Limited (RHT.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.022+0.001 (+4.762%)
At close: 3:33PM AEST

Resonance Health Limited

141 Burswood Road
Burswood, WA 6100
61 8 9286 5300

IndustryMedical Appliances & Equipment
Full Time Employees

Key Executives

Mr. Adrian R. BowersChief Financial Officer and Company Sec.142.06kN/AN/A
Dr. Timothy Guy St. Pierre B.Sc(Hons), Ph.D.Chief Scientific Officer208.43kN/AN/A
Ms. Melanie BaxterMarketing Director182.37kN/AN/A
Mr. Sander Bangma M.Sc, DipMgtGen. Mang.151.62kN/AN/A
Ms. Celine Royet Pharm.D.Quality Assurance and Regulatory Affairs Mang.111.22kN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Resonance Health Limited, a healthcare company, engages in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality controlled environment worldwide. The company’s non-invasive magnetic resonance imaging based products include FerriScan, a technology used in the measurement of liver iron concentration; and HepaFat-Scan, a solution for measuring the volume fraction of fat in liver tissue. It also provides clinical trial services, such as project management, reporting, and data management for pharmaceutical companies. The company is headquartered in Claremont, Australia.

Corporate Governance

Resonance Health Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.